Copyright
©The Author(s) 2024.
World J Clin Cases. Jun 26, 2024; 12(18): 3395-3402
Published online Jun 26, 2024. doi: 10.12998/wjcc.v12.i18.3395
Published online Jun 26, 2024. doi: 10.12998/wjcc.v12.i18.3395
Liver function indicators | Stage | Liver cancer resection group (n = 35) | Liver cancer ablation group (n = 35) | t | P value |
TBil (μmol/L) | Before treatment | 58.13 ± 10.65 | 58.79 ± 11.54 | 0.249 | 0.804 |
After one month of treatment | 49.18 ± 8.64a | 41.24 ± 7.35a | 4.141 | < 0.001 | |
ALT (U/L) | Before treatment | 48.21 ± 9.98 | 48.58 ± 9.37 | 0.159 | 0.873 |
After one month of treatment | 42.32 ± 7.56a | 30.85 ± 6.23a | 6.927 | < 0.001 |
- Citation: Yao LJ, Zhu XD, Zhou LM, Zhang LL, Liu NN, Chen M, Wang JY, Hu SJ. Short-term efficacy of microwave ablation in the treatment of liver cancer and its effect on immune function. World J Clin Cases 2024; 12(18): 3395-3402
- URL: https://www.wjgnet.com/2307-8960/full/v12/i18/3395.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i18.3395